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Abstract
Background: Treating youth with serious emotional disturbances
(SED) is expensive often requiring institutional care. A significant
amount of recent federal and state funding has been dedicated to
expanding home and community-based services for these youth as
an alternative to institutional care. High Fidelity Wraparound
(Wrap) is an evolving, evidence-informed practice to help sustain
community-based placements for youth with an SED through the
use of intensive, customized care coordination among parents,
multiple child-serving agencies, and providers. While there is
growing evidence on the benefits of Wrap, few studies have
examined health care spending associated with Wrap participation
and none have examined spending patterns after the completion of
Wrap. Merging health care spending data from multiple agencies
and programs allows for a more complete picture of the health care
costs of treating these youth in a system-of-care framework.
Aims of Study: (i) To compare overall health care spending for
youth who transitioned from institutional care into Wrap (the
treatment group) versus youth not receiving Wrap (the control
group) and (ii) to compare changes in health care spending, overall
and by category, for both groups before (the pre-period) and after
(the post-period) Wrap participation.
Methods: The treatment group (N=161) is matched to the control
group (N=324) temporally based on the month the youth entered
institutional care. Both total health care spending and spending by
category are compared for each group pre- and post-Wrap
participation. The post-period includes the time in which the youth
was receiving Wrap services and one year afterwards to capture
long-term cost impacts.
Results: In the year before Wrap participation, the treatment group

averaged $8,433 in monthly health care spending versus $4,599 for
the control group. Wrap participation led to an additional reduction
of $1,130 in monthly health care spending as compared to the
control group in the post-period. For youth participating in Wrap,
these spending reductions were the result of decreases in mental
health inpatient spending and general outpatient spending.
Discussion: Youth participating in Wrap had much higher average
monthly costs than youth in the control group for the year prior to
entering Wrap, suggesting that the intervention targeted youth with
the highest mental health utilization and likely more complex needs.
While both groups experienced reductions in spending, the
treatment group experienced larger absolute reductions, but smaller
relative reductions associated with participation. These differences
were driven mainly by reductions in mental health inpatient
spending. Larger reductions in general outpatient spending for the
treatment group suggest spillover benefits in terms of physical
health care spending. Further analysis is needed to assess how these
spending changes impacted health outcomes.
Implications for Health Policies: Wrap or similar programs may
lead to reductions in health care spending. This is the first study to
find evidence of longer-term spending reductions for up to a year
after Wrap participation.
Implications for Further Research: Randomized trials or some
other source of plausibly exogenous variation in Wrap participation
is needed to further assess the causal impact of Wrap on health care
spending, outcomes, or broader system-of-care spending.
Received 30 December 2016; accepted 6 November 2017
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Approximately 20 percent of all youth less than 19 years of
age have a diagnosable mental health disorder.1,2 One in ten
youth have a mental health disorder severe enough to impair
their functioning in their home, school, and community.3,4
Previous studies demonstrate that institutional care for youth
with severe emotional disturbances (SED) is expensive.5,6
The Substance Abuse and Mental Health Service
Administration (SAMHSA) defines individuals less than 18
years of age with an SED as having ‘‘a diagnosable mental,
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behavioral, or emotional disorder of sufficient duration to
meet Diagnostic and Statistical Manual of Mental Disorders
criteria that results in a functional impairment which
substantially intereferes with or limits the child’s role or
functioning in family, school or community activities.’’7 The
Deficit Reduction Act of 2005 authorized $218 million in
funding to ten states to develop five-year demonstration
programs that provide community alternatives to Psychiatric
Residential Treatment Facility (PRTF) level of care through
home and community-based services for youth with an SED.
Several states utilized the Alternatives to PRTF
Demonstration Grant to help divert and/or transition youth
with SEDs from PRTFs through the implementation or
expansion of High Fidelity Wraparound (Wrap).
Since the term was first coined in the 1980s, Wrap has
been described in various ways including as a philosophy, an
approach, and a service. More recently the National
Wraparound Initiative defined Wrap as ‘‘an intensive,
individualized care planning and management process.’’8
The values of Wrap are consistent with the System of Care
framework. Key characteristics of the process are that
individualized, strength-based, culturally competent plans are
developed by a family-centered team, driven by the
preferences and needs of the youth and family. Through the
team-based planning and implementation process, Wrap aims
to develop problem-solving skills, coping skills, and selfefficacy of the youth and family members that support
integrating the youth into the community and building the
family’s social support network.9
Since 2003, 10 controlled studies have been published on
the effectiveness of Wrap for youth involved in the mental
health, child welfare and juvenile justice systems.10 Most of
these studies focus on the effectiveness of Wrap as measured
by some subset of the following outcomes: reductions in
residential placements, improved mental health outcomes,
school success, and juvenile justice recidivism.11 However,
very few of these studies address the impact of Wrap on
health care costs, despite some states and jurisdictions
reporting residential and psychiatric hospitalization cost
savings from implementing Wrap.12
One study by Grimes et al. evaluated the costs and
outcomes of the Mental Health Services Program for Youth
(MHSPY) in Massachusetts, a Medicaid-funded
demonstration project that draws on the principles of Wrap to
serve youth with a diagnosed mental illness resulting in
significant clinical impairment, a current out-of-home
placement, or places the youth at imminent risk for an out-ofhome placement.13 The authors note that this Wrap model
was implemented through a clinical care management entity
and included intensive clinical oversight, potentially
distinguishing it from other Wrap models that focus solely on
care coordination. In Grimes’ study, Medicaid claims from
2005 and 2006 were used to compare health service
utilization by spending category (including pharmacy) for
youth enrolled in Wrap to Medicaid enrolled youth receiving
‘‘usual care.’’ Propensity score matching was used to reduce
potential differences between the Wrap and usual care
groups. Despite matching on diagnosis and prior hospital
use, the usual care group still had less psychiatric
168
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impairment. It does not appear as though the Wrap and usual
care groups were matched based on the timing of their
transition from high-intensity care. Results comparing
average monthly expenditures per child indicated that the
average costs of youth participating in Wrap exceeded the
average costs of the usual care group that only received
outpatient mental health services, but were less than those
who had at least one inpatient stay. Grimes’ study did not
consider costs after discharge from Wrap, but stressed that it
was an important topic for future research.
Another study described results from an evaluation of a
congressionally mandated Wrap demonstration for child and
adolescent dependents of military personnel.14 Behavioral
health service utilization and costs (not including pharmacy)
of youth receiving Wrap were compared to a usual care
group. It does not appear as though the Wrap and usual care
groups were matched based on the timing of their transition
from high-intensity care. The authors note that composing
the comparison group was a challenge and decided to use
families who refused Wrap services or were ineligible. The
two groups were similar at baseline in terms of three
measures of acuity and 30 months of cost data. Average costs
fell for both groups during the 14 months of services, but
these costs decreased twice as quickly among the usual care
group. This was primarily due to the addition of
nontraditional care (Wrap) in excess of traditional care costs
for children participating in Wrap.
A final study described a national evaluation of ten states
receiving funding via the Alternatives to PRTF
Demonstration Grant. 15 This cost analysis did not use
individual data, but rather average cost data for children in
Wrap collected from participating states, along with similar
cost data for children enrolled in PRTF care. Given the
approach, it was not possible to match on demographic
characteristics or the start date of PRTF care. Costs were
measured globally including the actual cost of providing
Wrap services, along with costs associated with all other
services paid for by Medicaid. Urdapilleta’s analysis did not
stratify costs by category of service. Descriptive results
suggested that Wrap may be associated with improvements
in clinical and functional outcomes, as well as significant
cost savings, during the provision of Wrap.15
This paper compares average monthly health care spending
for youth in a southeastern state transitioning from
institutional care into Wrap to youth who started institutional
care at the same time but who did not receive Wrap. Unlike
the previous literature, this study compares combined costs
both during and the year after Wrap participation to spending
in the previous year, making it the first study to consider the
impact of Wrap on long-term health care spending. An
additional contribution of this work is that both total health
care spending as well as several distinct categories of
spending (emergency room [ER]/inpatient, mental health
inpatient, general outpatient, mental health outpatient, and
pharmacy spending) are included. Finally, this study focuses
on youth transitioning from institutional care into Wrap rather
than those being diverted from institutional care into Wrap
because there may be differential effects for these two groups.
Previous cost studies appear to combine these groups.
ANGELA SNYDER ET. AL.
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This study found that mean monthly health care spending
was higher for the treatment group relative to the control
group ($8,433 versus $4,599) in the year before Wrap
participation. Wrap participation led to an additional
reduction of $1,130 in monthly health care spending
compared to the control group during the post-period. For
youth participating in Wrap these spending reductions
resulted from decreases in mental health inpatient spending
and general outpatient spending.

Aims of the Study
The primary study aim is to compare overall health care
spending for youth with SEDs who transitioned from
institutional care into Wrap (the treatment group) versus
youth starting institutional care at the same time, but not
receiving Wrap (the control group). The secondary aim is to
compare changes in health care spending, overall and by
category, for both groups during and the year after Wrap
participation to prior year spending.

Youth 1 from the treatment group has the longest possible
Wrap episode (from August 2009 to December 2011), given
the timing of the study sample. This youth was observed for
29 months during their Wrap episode, as well as 12 months
before and 12 months after, for a total of 53 months (12 preperiod and 41 post-period). This youth’s Wrap episode was
initiated August 2009 during transition from an institutional
care stay that started in August 2008. This episode is
matched to youth 1 from the control group who was admitted
to institutional care in August 2008 and continuously
enrolled in Medicaid for the same 53-month period.
Youth 2 from the treatment group had an 18-month Wrap
episode that started January 2010 during transition from an
intuitional care stay that started in August 2009. This youth’s
12-month pre-period consisted of seven months in the
community followed by five months in institutional care.
This youth was observed for a total of 42 months (12 preperiod and 30 post-period). Youth 2 from the treatment
group was matched with a youth from the control group who
similarly started an institutional care stay in August 2009.

Data
Methods

This analysis used Medicaid administrative enrollment and
claims data from a southeastern state between August 2008
and December 2012. The data was augmented with claims
The treatment group consisted of youth transitioning from
paid directly by the State Behavioral Health Authority for
institutional (PRTF) care into Wrap. Total health care
behavioral health services not covered by Medicaid. The
spending in the 12 months before Wrap participation (the
treatment group consisted of 161 youth between the ages of
pre-period) was compared to spending in the combined time
six and 20 years who were continuously enrolled in
during and 12 months after participation in Wrap (the postMedicaid, diagnosed with an SED with a Child and
period). Youth who did not participate in Wrap served as a
Adolescent Functional Assessment Score (CAFAS) greater
control group in this analysis. Youth in both groups had a
than 120, and enrolled in a first Wrap episode between
diagnosis and duration of symptoms which classified their
August 2009 and December 2011. Youth were continuously
illness as SED. The two groups were matched temporally on
enrolled in Medicaid during their Wrap episode, as well as
the start date of their institutional care stay because they had
12 months before and 12 months afterwards. Thus, the total
similar functional assessment scores and met an institutional
number of months observed for each youth was dependent
level of care. Treatment youth exited their institutional care
on the duration of his/her Wrap episode.
stay via participation in Wrap, while control youth may have
remained in institutional care or been previously discharged.
By restricting the start date of the treatment group in the
sample to August 2009 or later, total health care spending
The average length of stay in these institutional care episodes
could be observed for the full 12-month pre-period.
was 274 days for youth in the treatment group and 169 days
Similarly, by restricting the end date of the treatment group
for youth in the control group. Thus, temporal matching
in the sample to December 2011 or earlier, the treatment
among youth in the treatment group was not based on the
group’s total health care spending for the full 12-month
start of Wrap participation. Total health care spending is
stratified into several distinct categories, including:
period after Wrap treatment concluded was included in the
emergency room ER/inpatient, mental health inpatient,
post-period. The 161 youth in the treatment group were
general outpatient, mental health outpatient, and pharmacy
matched to 324 controls: 46 youth (1:1 match), 67 youth (1:2
match), and 48 youth (1:3 match). Thus, the total sample size
spending.
was 485 youth. Youth in the control group were also
On average, youth in the treatment group were enrolled in
continuously enrolled in Medicaid, diagnosed with an SED
Wrap for nine months. Each youth’s health care spending
with a CAFAS greater than 120; however, they were not
was tracked for an additional 12 months to include a longenrolled in Wrap during the study period.
term component in the post-period. This made the average
length of the post-period 21 months. For each youth in the
To give more detail regarding the definitions of the
treatment group, their temporally paired controls were
variables used in the analysis, urbanicity was defined using
assigned the same post-period in order to compare spending
the U.S. Department of Agriculture’s 9-point Rural Urban
patterns over the same timeframe.
Continuum Code, with ‘‘1’’ being the most urban and ‘‘9’’
being the least. A youth’s residence at the start of the postFigure 1 illustrates a sample of Wrap episodes (in grey) for
period was considered urban if it measured a ‘‘1,’’ ‘‘2,’’ or
youth in the treatment group matched temporally to their
‘‘3’’ on this continuum. Wrap spending refered to spending
controls.
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Figure 1. Sample Wrap Treatment Episodes.
Notes: INP stands for inpatient mental health hospitalization, Wrap stands for Wraparound care, and LT stands for long term.

Table 1. Descriptive Statistics.
Treatment group

Control group

161

324

12.00
20.92

12.00
21.15

Pre-Wrap Monthly Spending***
Post-Wrap Monthly Spending***, ^^^

8,433.23
5,175.16

4,598.92
2,471.11

Age 6-10***
Age 11-15*
Age 16-20***
Female
Urban
Foster*

19.25%
56.52%
24.22%
38.51%
86.34%
37.27%

6.48%
47.53%
45.99%
40.12%
82.72%
45.37%

Sample Size
Pre-Wrap Monthly Duration
Post-Wrap Monthly Duration

Source: Medicaid administrative data from a southeastern state.
Notes: *** implies the difference between the treatment and control group is statistically significant at the 1% level, ** implies the difference between the
treatment and control group is statistically significant at the 5% level, and * the difference between the treatment and control group is statistically significant at
the 10% level. ^^^ implies the difference between pre- and post-WRAP spending is statistically significant at the 1% level, ^^ implies the difference between preand post-WRAP spending is statistically significant at the 5% level, and ^ implies the difference between pre- and post-WRAP spending is statistically significant
at the 10% level.

on any services associated with the Wrap program. There
was no Wrap spending in the pre-period, so such spending
was only generated by the treatment group in the post-period.
ER/inpatient spending included any spending for services
received at a general hospital. MH inpatient spending refers
to any spending in a psychiatric residential treatment facility
(a PRTF stay) or a crisis stabilization unit. Outpatient
spending included general services received outside of a
hospital setting, such as a doctor’s office or laboratory. MH
outpatient spending refered to spending associated with a
mental health service received in the community. Finally,
pharmacy spending included all spending on
pharmaceuticals, regardless of the condition.

case in a difference-in-differences regression, a separate
indicator was included for those who participated in Wrap
(Wrapi), as well as an indicator for the post-period (Postt).

Results

Table 1 presents descriptive statistics for the sample. Mean
spending was significantly higher (p-value < 0.01) for the
treatment group relative to the controls ($8,433 vs. $4,599)
in the pre-period. In the post-period, mean spending
significantly fell for both the treatment ($5,175; a 39 percent
reduction, p-value < 0.01) and control ($2,471; a 46 percent
reduction, p-value < 0.01) groups, but spending in the
Statistical Analysis
treatment group continued to be significantly higher (p-value
< 0.01) than spending in the control group.
Descriptive statistics and mean total health care spending
Turning to demographic differences, the treatment group
were reported for the treatment group and the control group.
contained larger shares of young children than the control
Statistically significant differences were examined using tgroup (p-value < 0.01 for age categories 6-10 and 16-20
tests for continuous variables and chi-square tests for
years and p-value = 0.06 for age category 11-15 years). It
categorical variables. Similar comparisons were examined by
also had a smaller (p-value = 0.09) share of foster children
spending category. Next, a difference-in-differences
(defined as those ever in foster care during the study period).
regression was estimated using the following form for the
There was no statistically significant difference in the share
Wrap treatment and control groups:
of youth that resided in an urban area or the share of female
youth between the treatment and the control groups.
Spendingit = B0 + B1*Wrapi*Postt + B2*Wrapi + B3*Postt +
Table 2 reports mean spending by category. When
(1)
+ X*B4 + ai + eit
spending was stratified into the six categories, generally the
treatment group incurred more spending in the pre-period
In this equation, the vector X represented observed youth
than the controls, with the exception being MH outpatient
characteristics (age, gender, urban vs. rural, and foster status)
spending, which was significantly higher (p-value < 0.01) in
and ai represented youth fixed effects, which control for the
the control group ($508 vs. $229). For the post-period, the
unobserved youth characteristics that are time-invariant. The
treatment group incurred significantly higher ER/inpatient
primary coefficient of interest, B1, on the interaction between
spending ($238 vs. $161, p-value < 0.05), MH inpatient
the Wrap indicator and the post-period indicator represented
spending ($2,852 vs. $1,114, p-value < 0.01), and pharmacy
any change in spending as a result of participating in Wrap
spending ($537 vs. $357, p-value < 0.01), compared to the
for the treatment group relative to the change in spending for
control group.
the control group during the post-period. As is typically the
DO HIGH FIDELITY WRAPAROUND SERVICES FOR YOUTH WITH SERIOUS EMOTIONAL DISTURBANCES SAVE MONEY IN THE LONG-TERM?
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Table 2. Monthly Mean Spending by Category.
Treatment group

Control group

161

324

Mean Pre-Wrap Wrap Spending
Standard Deviation
Mean Post-Wrap Wrap Spending
Standard Deviation

0
N/A
693.27
42.16

0
N/A
0
N/A

Mean Pre-Wrap ER/Inpatient Spending
Standard Deviation
Mean Post-Wrap ER/Inpatient Spending***
Standard Deviation

281.27
49.44
238.36
32.67

263.13
32.41
160.93^^^
21.20

Mean Pre-Wrap MH Inpatient Spending***
Standard Deviation
Mean Post-Wrap MH Inpatient Spending***
Standard Deviation

6,915.04
250.72
2,851.69^^^
202.28

3,040.04
148.49
1,113.89^^^
100.49

391.66
62.48
263.60^
20.01

310.63
23.81
299.67
40.06

228.83
26.08
591.11^^^
33.96

507.82
32.24
539.37
28.62

616.43
43.58
537.12
36.16

477.3
25.19
357.24^^^
17.01

Sample size

Mean Pre-Wrap Outpatient Spending
Standard deviation
Mean Post-Wrap Outpatient Spending
Standard Deviation
Mean Pre-Wrap MH Outpatient Spending***
Standard Deviation
Mean Post-Wrap MH Outpatient Spending**
Standard Deviation
Mean Pre-Wrap Pharmacy Spending***
Standard Deviation
Mean Post-Wrap Pharmacy Spending***
standard deviation

Source: Medicaid aAdministrative data from a southeastern state.
Notes: Wrap spending refers to spending on any services associated with the Wraparound program. ER/inpatient spending include any spending for services
received at a general hospital. MH inpatient spending refers to any spending in a psychiatric residential treatment facility (a PRTF stay) or a crisis stabilization
unit. Outpatient spending includes general services received outside of a hospital setting, such as a doctor’s office or laboratory. MH outpatient spending refers to
spending associated with a mental health service received in the community. Finally, pharmacy spending includes all spending on pharmaceuticals, regardless of
the condition. *** implies the difference between the treatment and control group is statistically significant at the 1% level, ** implies the difference between the
treatment and control group is statistically significant at the 5% level, and * the difference between the treatment and control group is statistically significant at
the 10% level. ^^^ implies the difference between pre- and post-WRAP spending is statistically significant at the 1% level, ^^ implies the difference between preand post-WRAP spending is statistically significant at the 5% level, and ^ the difference between pre- and post-WRAP spending is statistically significant at the
10% level.

MH inpatient spending is the largest spending category for
both groups. In the post-period, both the treatment ($6,915 to
$2,852, p-value < 0.01) and control ($3,040 to $1,114, pvalue < 0.01) groups exhibited a statically significant
reduction in this spending category. By design, the treatment
group accrues spending on Wrap services ($693 over the
entire post period, $1,219 during Wrap participation), while
the control group never receives these services ($0).
Compared to the pre-period, ER/inpatient spending
significantly falls (p-value = 0.01) for the control group, but
not the treatment group. Outpatient spending decreases
significantly (p-value = 0.05) for the treatment group, but not
the control group. MH outpatient spending significantly
increases (p-value < 0.01) in the treatment group, but not the
control group. Pharmacy spending significantly decreases (pvalue < 0.01) for the control group, but not the treatment
group.
Table 3 presents estimates of equation (1) based on the
172
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Wrap and control groups described above. The results
suggest that Wrap led to a statistically significant reduction
Table 3. Baseline Regression Results.
Wrap*Post
Standard Error
P-Value

–1,130.26
306.95
0.000

Post
Standard Error
P-Value

–2,127.81
176.68
0.000

# Observations
# Children

1,455
485

Source: Medicaid administrative data from a southeastern state.
Notes: Child fixed effects are included in this regression, which control for
any observed or unobserved child characteristics that are time-invariant, such
as gender, race, or underlying health status.
ANGELA SNYDER ET. AL.
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Table 4. Post-Period Spending stratified by Category.
Spending Category
All

WRAP

ER/Inpatient

MH Inpatient

Outpatient

MH Outpatient

Prescription

Wrap*Post
Standard Error
P-Value

–1,130.26
306.95
0.000

693.27
47.78
0.000

59.29
57.75
0.305

–2,137.20
302.72
0.000

–117.10
66.65
0.079

330.73
62.57
0.000

40.75
34.01
0.231

Post
Standard Error
P-Value

–2,127.81
176.68
0.000

N/A

–102.20
33.27
0.002

–1,926,15
174.42
0.000

–10.96
28.40
0.775

31.55
36.05
0.382

–120.05
19.60
0.000

# Observations
# Youth

1,455
485

1,455
485

1,455
485

1,455
485

1,455
485

1,455
485

1,455
485

Source: Medicaid administrative data from a southeastern state.
Notes: Each column represents a separate difference-in-differences regression. In each regression child fixed effects are included, which control for any observed
or unobserved child characteristics that are time-invariant, such as gender, race, or underlying health status.

(p-value < 0.01) in average spending of $1,130 over and
above any change in spending for the control group. The
coefficient associated with the post indicator is an estimate of
the change in spending for the control group. Thus, the
control group experienced a $2,128 reduction (p-value <
0.01) in average spending. Taken together these two
coefficients imply that the treatment group experienced a
reduction in average spending of $1,130 + $2,128 = $3,258
in the post-period.
Table 4 stratifies spending by category. The first column
restates the total spending change result reported in Table 3;
the next six columns focus on particular sub-categories of
spending. Participation in Wrap resulted in statistically
significant reductions in MH inpatient spending ($2,137, pvalue < 0.01) and general outpatient spending ($117, p-value
= 0.08). Wrap participation led to a significant increase (pvalue < 0.01) in Wrap spending and MH outpatient spending
($330, p-value < 0.01). Table 4 also reports no statistically
significant change in ER/inpatient spending or pharmacy
spending. These results suggest that the overall reduction in
spending due to Wrap participation is driven by reductions in
MH inpatient spending and general outpatient spending that
more than compensate for an increase in MH outpatient
spending.
In other analyses not presented, the sample is stratified by
gender, foster care status, and age, separately. Generally,
females in the post-period have less health care spending
when compared to males in both the treatment and control
groups. Foster care status does not have an impact on postperiod spending. Generally, health care spending decreases
with increasing age.

same time but who did not transition into Wrap. Overall,
children transitioning into Wrap experienced a $1,130
reduction in average spending in the post-period. This
methodology is novel in that it includes spending for 12
months after the completion of Wrap in order to measure
longer-term effects. This is a 13 percent reduction in
spending, as compared to the treatment group’s pre-period
average monthly spending of $8,433. When costs are broken
down by category, these savings were mainly driven by
reductions in MH inpatient spending and general outpatient
spending. This suggests that Wrap may also have spillover
benefits in terms of physical health care spending.
By comparison, the National Alternatives to PRTF
Demonstration Evaluation found a 32 percent cost savings
when comparing health care spending during Wrap
enrollment to a similar period of residential treatment, 15
which is higher than the 13 percent reduction in spending
observed in this study. Results from the Wrap demonstration
for military dependents reported average behavioral health
costs fell for both the Wrap and usual care groups during
Wrap, but costs decreased twice as quickly among the usual
care group.14 Brickman’s study did not include other health
care or pharmacy costs which might partially explain why
costs decreased less quickly for the treatment group. Results
from the analysis of the MHSPY Wrap program showed that
average monthly expenditures per child during Wrap were
less than for a comparison group of youth who had at least
one inpatient stay. 13 Like the current study, the MHSPY
study also broke down costs into categories and found
reductions in mental health inpatient care to be the largest
cost driver. The researchers also observed reductions in acute
inpatient care and increased spending in pharmacy and
mental health outpatient care. The current study found
similar increases in MH outpatient spending in the postDiscussion
period; however, no statistically significant change in ER/
inpatient or pharmacy spending. This difference, with respect
to pharmacy spending, may be due to the more clinical
In this paper, health care spending for children who
nature of the MHSPY Wrap program.
transitioned from institutional care into Wrap was compared
This study is consistent with the previous literature in
with spending for children starting institutional care at the
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that: (i) results suggest reductions in health care spending
for youth participating in Wrap, (ii) these reductions are
mainly driven by a reduction in mental health inpatient
utilization and suggest spillover effects on physical health
care spending, and (iii) it is challenging to identify a group
of youth to serve as a control group who do not enter Wrap,
but who are otherwise similar. The literature finds mixed
results depending on the construction of the control or
comparison group. Despite the fact that the current study
matches on the timing of entry into institutional care to
ensure youth had similar acute needs, youth in the sample
who transitioned into Wrap had higher levels of pretransition health care spending than youth who did not
transition into Wrap. The decision to match temporally was
based on the outcome of post-Wrap spending patterns and
the nature of mental health service utilization more
generally. Consequently, sample size constraints prevent
further matching on other characteristics associated with
pre-intervention spending.
In summary, results from this study suggest that youth
enrolled in Wrap experience sustained average monthly
savings of $1,113 in overall health care spending for a year
after discontinuing Wrap services. When compared to youth
in institutional care who did not receive Wrap services, the
treatment group experiences larger absolute reductions
($3,258 vs. 2,128), but smaller relative reductions (39
percent vs. 46 percent), in the post-period. These differences
are mainly due to the fact that the Wrap intervention targeted
youth with the highest mental health utilization and likely
more complex needs. This suggests that Wrap and other
community-based alternatives to institutional care may be a
cost-effective addition to state mental health Systems of Care
both in the short- and long-term.

Limitations
This analysis focuses on health care spending and does not
evaluate whether Wrap is associated with changes in youth
functioning or behavioral health needs. In other words, the
focus is on costs rather than comparing costs to benefits. In
addition, both the proposed costs and benefits of Wrap
extend beyond government agencies associated with health
care into departments of education, welfare, and justice. For
example, one study found that foster youth graduating from
Wrap had significantly fewer out-of-home placements and
lower post-graduation costs than foster youth receiving
residential care.16 A complete evaluation of the impact of
Wrap should include such system-wide information,
however such data at the state or local level are seldom
captured in one database. For example, in the present
analysis of health care spending, data was merged from four
distinct data sources within two separate state agencies. In
terms of data, it is not possible to separate out the costs of
PRTF, crisis stabilization, and acute psychiatric care (within
the MH inpatient category of spending); however, the
overwhelming majority of these costs in this spending
category are for PRTF care. In terms of methods, the
inclusion of individual fixed effects to control for timeinvariant unobserved child characteristics comes at the cost
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of sweeping out cross-sectional variation in mean costs. This
could potentially be problematic given that the treatment and
control groups are matched temporally based on functional
assessment scores rather than on prior cost experience. It is
possible that these groups could experience differential
regression-to-the-mean. In addition, despite the inclusion of
an additional 12-month period after Wrap completion in the
post-period, this study included a relatively short panel that
could potentially lead to bias. For these reasons, study
findings should be interpreted with caution.

Implications for Health Care Provision and Use
Wrap has the potential to save money by substituting care
coordination in the community for institutional care. These
health care savings represent both immediate cost savings as
well as larger continued savings in the first year after Wrap
participation. Furthermore, spillover effects, in terms of less
use of outpatient physical health care, suggest that building a
family’s social support network and improving coping skills
may have added benefits of allowing youth with SED to
remain in the community with less need for intensive, costly
health services. These results are consistent with other care
coordination programs that address social determinants of
health being implemented as part of delivery systems
designed to support population health.17

Implications for Health Policies
States contemplating the introduction of care coordination
programs, such as Wrap, may achieve health care cost
savings as well as savings within other nonhealth state
agencies, such as juvenile justice and child welfare.
Evaluations of the costs and benefits of Wrap also contribute
to the broader policy debate about home and communitybased care versus institutional care, in general.

Implications for Further Research
Future research should focus on fully measuring the systemwide costs and benefits of Wrap to provide a complete
picture of the cost-effectiveness of such care coordination. In
addition, while this study is the first to report cost estimates
for youth in the year after Wrap participation, further
research is needed to assess the longer-term impacts of Wrap.
Additional analysis could also be done to study the impacts
of Wrap on youth being diverted from institutional care or
youth with high needs who do not yet meet an institutional
level of care. Finally, randomized assignment into Wrap for
research purposes would be a potential solution to the
challenges created by differences between the treatment and
control groups in quasi-experimental settings.
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